In accordance with Article 7(1) of Regulation (EC) No 1107/2009, Belgium received on 22 January 2013 an application from ISK Biosciences Europe NV for the approval of the active substance isofetamid.
Recital 1, Regulation (EU) 2016/1425
In forcesince 25 Aug 2016